Content provided by Univar Solutions USA | 07-Oct-2024
| Product Brochure
In partnership with our industry-leading supplier partners, Univar Solutions Pharmaceutical Ingredients is proud to introduce Powering Healthy Tomorrows.
Content provided by Asahi Kasei Medical Co., Ltd. | 24-Sep-2024
| White Paper
Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...
Content provided by Almac Group | 19-Sep-2024
| White Paper
Solid phase peptide synthesis (SPPS) is generally the method of choice for the chemical synthesis of peptides, allowing routine synthesis of virtually...
Content provided by Univar Solutions USA | 28-Aug-2024
| Product Brochure
Univar Solutions Pharmaceutical Ingredients is proud to offer one of the most expansive portfolios of 15,000+ products, including high-purity solvents,...
Thermo Fisher Scientific – Production Chemicals and Services | Recorded the 17-Sep-2024 | Webinar
Bispecific antibodies (BisAbs), which can bind to two distinct antigens, are prone to high levels of aggregate (10-30%), challenging traditional platform...
Crosslinking is a natural phenomenon occurring in gelatin that negatively impacts soft capsules, reducing their stability and prolonging their dissolution...
Content provided by Saama | 25-Mar-2024
| Infographic
In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...
Content provided by Almac Group | 12-Feb-2024
| Case Study
Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...
Content provided by Saama | 08-Feb-2024
| White Paper
the exponential growth of data points flowing into clinical study databases. As technologies help researchers to reach more patients all over the world,...
Content provided by Almac Group | 29-Nov-2023
| White Paper
Solvents are defined as organic chemicals that are used to dissolve components. They are used during the manufacture of drug substances and can also potentially...
Content provided by Formedix | 14-Nov-2023
| White Paper
It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...
Content provided by Lonza Small Molecules | 13-Nov-2023
| White Paper
Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract
Content provided by Single Use Support | 06-Nov-2023
| White Paper
Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...
Content provided by WuXi AppTec | 01-Nov-2023
| Application Note
The use of internal standards (IS) is essential for developing and applying liquid chromatography-tandem mass spectrometric (LC-MS/MS) quantitative bioanalytical...
Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023
| Case Study
A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...
Content provided by Formedix | 01-Nov-2023
| White Paper
New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...
Content provided by WuXi AppTec | 20-Oct-2023
| Application Note
Global regulatory standards govern bioanalytical method development, validation and the subsequent assays. When those standards are updated, industry stakeholders...
Content provided by Catalent Pharma Solutions | 19-Oct-2023
| Business Advice
New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...
Content provided by Lonza | 12-Oct-2023
| White Paper
Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...
Content provided by Lonza Small Molecules | 09-Oct-2023
| White Paper
Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...
Content provided by Altasciences | 28-Sep-2023
| White Paper
In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...
Content provided by Lonza Capsules & Health Ingredients | 27-Sep-2023
| White Paper
International Journal of Pharmceutics: In Vitro: The dissolution characteristics of five capsules (Next Generation Enteric [NGE], Vcaps® Enteric [VCE],...
Content provided by Lonza Capsules & Health Ingredients | 01-Sep-2023
| White Paper
Invivo: Many orally dosed APIs are bioavailable only when formulated as an enteric dosage form to protect them from the harsh environment of the stomach....
Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023
| White Paper
Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...
Content provided by Bora Pharmaceuticals | 10-Aug-2023
| White Paper
Successfully manufacturing a drug product requires people, proper equipment, and materials. It’s the classic three-legged stool analogy. Even with well-trained...
Content provided by Formedix | 01-Aug-2023
| White Paper
When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...
Content provided by Lonza Small Molecules | 11-Jul-2023
| Insight Guide
With the complexities associated with API and HPAPI drug development, it’s necessary to lean on the experts. With Q&A sections, insights and articles...
Content provided by Lonza Small Molecules | 20-Jun-2023
| Insight Guide
Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...
Content provided by Formedix | 19-Jun-2023
| White Paper
In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...
Content provided by Bora Pharmaceuticals | 13-Jun-2023
| White Paper
The biopharma landscape is forever changing, and with it, a demand from both patients and investors for the rapid development and progression of drug products...
Content provided by Formedix | 12-May-2023
| White Paper
What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....
Content provided by Altasciences | 02-May-2023
| White Paper
As a leading partner in central nervous system (CNS) drug development, Altasciences’ in-house preclinical, clinical, bioanalytical, and manufacturing teams...
Content provided by Formedix | 17-Apr-2023
| White Paper
Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....
Content provided by Elligo Health Research® | 13-Apr-2023
| Insight Guide
You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...
Content provided by Florence Healthcare | 01-Apr-2023
| Insight Guide
Shifting to eRegulatory and eSource workflows is a requirement for clinical trial sites to continue to scale and grow their studies. This guide is designed...
Content provided by Lonza Small Molecules | 28-Mar-2023
| White Paper
A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways...
Content provided by Elligo Health Research® | 23-Mar-2023
| Insight Guide
On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...
Content provided by Indena | 15-Mar-2023
| White Paper
Indena offers custom development by leveraging the expertise of a specialized team devoted to designing and developing processes and analytical methods....
Content provided by Catalent | 08-Mar-2023
| Infographic
With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader...
Content provided by Florence Healthcare | 08-Mar-2023
| Insight Guide
89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...
